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ABBREVIATIONS 
BSS  Brooke-Spiegler syndrome 
NHEK  Normal human epidermal keratinocytes 
PBMC  Peripheral blood mononuclear cells 
PTC  Premature termination codon 
qRT-PCR Quantitative reverse transcriptase polymerase chain reaction 
RT-PCR Reverse transcriptase polymerase chain reaction 
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EDITOR, 
Brooke-Spiegler syndrome (BSS; OMIM 605041), also known as familial cylindromatosis 
(OMIM 132700), is an autosomal dominant tumour predisposition disorder characterised by 
the occurrence of cylindromas, trichoepitheliomas, and spiradenomas.1 BSS is caused by 
heterogenous mutations in the CYLD gene. To date, different CYLD mutations have been 
reported, most of them resulting in a premature termination codon (PTC).2 Among these, 
thirteen splice site mutations have been described.2,3 However, it remains largely elusive 
how such mutations affect splicing.2  
 
Here, we studied three unrelated Caucasian patients with BSS who were initially diagnosed 
both clinically and histopathologically (Table 1). To unequivocally confirm the diagnosis, we 
performed mutation analysis of the CYLD gene which revealed three splice site mutations. In 
order to select appropriate tissues for RNA studies, we assessed the expression of CYLD in 
normal human epidermal keratinocytes (NHEK), leukocytes and peripheral blood 
mononuclear cells (PBMC) by quantitative reverse transcriptase (qRT)-PCR. In all patients, 
residual mRNA levels were measured in RNA specimens derived from whole blood.  
 
We detected three CYLD splice site mutations, designated c.2108+1G>A (Fig. 1a), c.2242-
2A>G (Fig. 1b), and c.2109-2A>C (Fig. 1c). These mutations were associated with distinct 
phenotypes, respectively (Table 1). Interestingly, the first patient carried a novel mutation 
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that was not detectable in either parent. Paternity was confirmed by haplotype analysis (data 
not shown). To the best of our knowledge, c.2108+1G>A represents the first de novo 
mutation reported in BSS. All mutations were shown by restriction enzyme digestion to be 
absent from 100 unrelated, unaffected Caucasian control individuals (data not shown).  
 
Comparison of mRNA expression by RT-PCR revealed that CYLD is expressed at almost 
equal levels in NHEK, leukocytes and PBMC (data not shown). In the patients carrying 
mutations c.2108+1G>A and c.2242-2A>G, RT-PCR on RNA derived from PBMCs revealed 
the wild-type product containing 430 base pairs (bp) and a smaller additional band of 363 
and 321 bp, respectively. Automated DNA sequencing showed that the smaller bands 
represented fragments excluding exons 15 and 17, respectively (data not shown). Both exon 
skipping events lead to putative out-of-frame translation and generation of a PTC. For 
mutation c.2108+1G>A the PTC is located 30 codons downstream of the mutation site 
(p.Pro682Gln31fs*) and for c.2242-2A>G, 47 codons downstream of the mutation 
(p.Ala748Leufs48*). Of note, we did not detect an aberrant splicing pattern for c.2109-2A>C. 
This finding suggested that the transcript of the mutated allele is subject to nonsense-
mediated mRNA decay. 
To study the role of nonsense-mediated mRNA decay in the three splice site mutations 
detected here, we measured CYLD mRNA expression in peripheral blood leukocytes by 
qRT-PCR. Whereas mutations c.2108+1G>A and c.2242-2A>G do not result in a significant 
decrease of mRNA levels, mutation c.2109-2A>C is associated with approximately 60% 
mRNA decay when compared to a control (Fig. 1d). 
The patient harbouring mutation c.2109-2A>C presented with cylindromas exclusively. This 
mutation has been previously reported in a family with trichoepitheliomas only, which 
suggests that the residual amounts of CYLD mRNA seem to be unrelated to the distinct 
phenotypes of individuals with this CYLD splice site defect.4 To date, fifteen splice site 
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mutations have been reported to underlie different phenotypes, comprising Brooke-Spiegler 
syndrome (30%), familial cylindromatosis (35%), and multiple familial trichoepithelioma 
(35%).2,3 These previous reports and our own data confirm the previous notion that there is 
no apparent genotype-phenotype correlation in diseases caused by CYLD mutations.2 
Possibly, as of yet unknown environmental factors, modifier genes or epigenetic events 
could contribute to the different phenotypes observed.5,6 
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LEGENDS TO TABLE AND FIGURES 
Table 1 CYLD splice site mutations in this study, associated phenotypes, and   
  the structural and functional consequences of these mutations. 
Figure 1 a-c) Splice site mutations detected in this study, designated  c.2108+1G>A; 
c.2242-2A>G; and c.2109-2A>C. d) Quantitative real-time PCR indicates that 
mutations C.2108+1G>A and C.2242-2A>G are not associated with relevant 
mRNA decay. By contrast, mutation C.2109-2A>C leads to substantial mRNA 
decay. 
Mutation c.2108+1G>A c.2242-2A>G c.2109-2A>C 
Phenotype Cylindromas and 
trichoepitheliomas 
Cylindromas and 
trichoepitheliomas 
Cylindromas  
Novel or recurrent 
mutation 
Novel Novel Recurrent 
Consequence of 
splicing defect 
Exon skipping Exon skipping Nonsense-mediated 
mRNA decay 
Levels of mRNA Normal  Normal   40% of normal  
 
Table 1 CYLD splice site mutations in this study, associated phenotypes as well as 
  the structural and functional consequences of these mutations. 
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